NSCLC Initiative

Back to Portal
Scientific Council

Copyright © 2026 | NSCLC ADVANCES Initiative | All Rights Reserved | Website by Divigner

Clinician Toolkit

Clinician Scientific & Educational Resources

Explore the ADVANCES Clinician Toolkit, designed as a comprehensive resource center for healthcare providers who deliver care to patients with NSCLC, regardless of PD-L1 expression.

Our goals are to provide information that supports open communication between patients and providers and to improve patient care.

HD Visual Learning

  • Dynamic HD animations about ROP
  • Interactive, downloadable learning tools for mobile devices

Expert Spotlights

View Expert Spotlight

Introduction

Introduction

Overview of NSCLC

Read more

Rationale for Immunotherapy in NSCLC

Rationale for Immunotherapy in NSCLC

Explore the immunopathologic factors in the pathogenesis of NSCLC

Read more

Biomarker-Directed Use of Immune Checkpoint Inhibitors for NSCLC

Biomarker-Directed Use of Immune Checkpoint Inhibitors for NSCLC

Review strategies for targeting NSCLC based on appropriate application of clinical biomarkers

Read more

Clinical Trials of First-Line Therapies for NSCLC

Clinical Trials of First-Line Therapies for NSCLC

Up-to-date clinical trial data concerning front-line use of immuno-oncology strategies in NSCLC

Read more

Reading and Resources

Reading and Resources

Links to further education and resources

Read more

This activity is provided by Med Learning Group.
This activity is supported by an independent educational grant from Regeneron Pharmaceuticals, Inc.

Copyright © 2026 | NSCLS ADVANCES Initiative| All Rights Reserved | Website by Divigner

Scientific Council

Neil M. Bressler, MD

James P. Gills Professor of Ophthalmology
Professor of Ophthalmology, Johns Hopkins University School of Medicine
Wilmer Eye Institute, Johns Hopkins Medicine
Baltimore, MD

A. Paul Chous, MA, OD, FAAO

Specializing in Diabetes Eye Care & Education, Chous Eye Care Associates
Adjunct Professor of Optometry, Western University of Health Sciences
AOA Representative, National Diabetes Education Program
Tacoma, WA

Steven Ferrucci, OD, FAAO

Chief of Optometry, Sepulveda VA Medical Center
Professor, Southern California College of Optometry at Marshall B. Ketchum University
Sepulveda, CA

Julia A. Haller, MD

Ophthalmologist-in-Chief
Wills Eye Hospital
Philadelphia, PA

Allen C. Ho, MD, FACS

Director, Retina Research
Wills Eye Hospital
Professor and Chair of the Department of Ophthalmology
Thomas Jefferson University Hospitals
Philadelphia, PA

Charles C. Wykoff, MD, PhD

Director of Research, Retina Consultants of Houston
Associate Professor of Clinical Ophthalmology
Blanton Eye Institute & Houston Methodist Hospital
Houston, TX

Did you come from ENCOMPASS?

Did you come from encompass-cancer.com?

View more tumor types at encompass-cancer.com

Search

[divi_global_search_form]

Español

Retinopathy of Prematurity

Back to Portal
Scientific Council

Copyright © 2020 | ROP Relief | All Rights Reserved | Website by Divigner

Directory
Directory
Search
Search

Español

Clinician Scientific & Educational Resources

The RELIEF Clinical Toolkit is an online tool that aims to provide clinicians with up-to-date information on the presentation, prognosis, pathophysiology, and treatment strategies for retinopathy of prematurity (ROP). Click on one of the options below to learn more about ROP.

HD Visual Learning

  • Dynamic HD animations about ROP
  • Interactive, downloadable learning tools for mobile devices

Patient Toolkit

Patient Toolkit

Read more

What exactly is NSCLC?

What exactly is NSCLC?

Read more

What symptoms can NSCLC cause?

What symptoms can NSCLC cause?

Read more

How is NSCLC treated according to staging?

How is NSCLC treated according to staging?

Read more

How is early NSCLC treated with surgery or SBRT?

How is early NSCLC treated with surgery or SBRT?

Read more

When is chemotherapy used in NSCLC?

When is chemotherapy used in NSCLC?

Read more

When is radiation used in NSCLC?

When is radiation used in NSCLC?

Read more

When is immunotherapy used in NSCLC?

When is immunotherapy used in NSCLC?

Read more

When is targeted therapy used in NSCLC?

When is targeted therapy used in NSCLC?

Read more

Patient Journey

Patient Journey

Read more

Online resources

Online resources

Read more
This activity is provided by Med Learning Group. This activity is co-provided by Ultimate Medical Academy/Complete Conference Management (CCM). This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Copyright © 2019 | ROP Relief | All Rights Reserved | Website by Divigner